 | Arbutus to Participate at H.C. Wainwright Bioconnect Virtual Conference
finance.yahoo.com - January 4 at 11:12 AM |
| Antios Therapeutics and Arbutus Biopharma Announce First Patient Dosed in Phase 2a Combination Trial of ATI-2173, AB-729 and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B Virus Infection
finance.yahoo.com - December 14 at 12:57 PM |
 | Arbutus, Qilu To Develop, Commercialize AB-729 In Mainland China, Hong Kong, Macau And Taiwan
nasdaq.com - December 13 at 11:54 AM |
 | Why Arbutus Biopharma Shares Are Rising
markets.businessinsider.com - December 13 at 11:54 AM |
| Arbutus and Qilu Pharmaceutical Enter into an Exclusive Licensing Agreement and Strategic Partnership to Develop and Commercialize AB-729 in mainland China, Hong Kong, Macau and Taiwan
finance.yahoo.com - December 13 at 11:54 AM |
| Arbutus enters into $300M deal for experimental hepatitis B drug with Chinese pharma firm
finance.yahoo.com - December 13 at 11:54 AM |
 | Lab Notes: Arbutus and Penn make headway on Covid-19 treatments; Carisma partners with Merck
bizjournals.com - December 10 at 1:49 PM |
| Keep on Buying Arbutus Stock Before It Jumps 80%, Says Analyst
nasdaq.com - December 9 at 5:16 PM |
| Keep on Buying Arbutus Stock Before It Jumps 80%, Says Analyst
finance.yahoo.com - December 9 at 5:16 PM |
| Arbutus Biopharma Shares Jump After Achieving First Milestone Under COVID-19 Pact
markets.businessinsider.com - December 7 at 12:52 PM |
|
| Arbutus Biopharma, X-Chem and Proteros biostructures Achieve First Milestone Under COVID-19 Discovery Research and License Agreement
finance.yahoo.com - December 7 at 7:52 AM |
 | Arbutus Shares Rise Moderna's Fall After Patent Appeal Denied
msn.com - December 2 at 8:08 PM |
| Arbutus: Still Plenty of Upside Left Following Favorable Court Decision
finance.yahoo.com - December 2 at 3:07 PM |
| Preliminary Data Shows that Arbutus’ Capsid Inhibitor, AB-836 is Generally Safe and Well-Tolerated and Provides Robust Antiviral Activity
finance.yahoo.com - December 1 at 1:35 PM |
| Why Arbutus Biopharma Is Rocketing Higher Today
finance.yahoo.com - December 1 at 1:35 PM |
| Arbutus Biopharma Appoints Tram Tran, M.D. to its Board of Directors
finance.yahoo.com - November 11 at 7:37 AM |
| Arbutus Announces New Data on AB-729 in Late Breaker Poster Presentation at AASLD - The Liver Meeting®
finance.yahoo.com - November 10 at 8:39 PM |
| Arbutus to Participate at Jefferies London Healthcare Conference
finance.yahoo.com - November 10 at 10:38 AM |
| Arbutus Biopharma (ABUS) Q3 2021 Earnings Call Transcript
finance.yahoo.com - November 5 at 1:23 AM |
| Arbutus Biopharma (ABUS) Reports Q3 Loss, Tops Revenue Estimates
msn.com - November 4 at 10:17 AM |
| Arbutus Reports Third Quarter 2021 Financial Results and Provides Corporate Update
finance.yahoo.com - November 4 at 10:17 AM |
| Arbutus to Report Third Quarter 2021 Financial Results and Provide Corporate Update
finance.yahoo.com - October 21 at 9:49 AM |
| Arbutus Biopharma (NASDAQ:ABUS) shareholders have earned a 7.3% CAGR over the last five years
finance.yahoo.com - October 13 at 9:26 AM |
| What Kind Of Investors Own Most Of Arbutus Biopharma Corporation (NASDAQ:ABUS)?
nasdaq.com - October 3 at 10:24 AM |
| Arbutus to Participate in October Investor Conferences
finance.yahoo.com - September 28 at 9:16 AM |
| Arbutus Appoints Lisa M. Caperelli as Vice President, Investor Relations
finance.yahoo.com - September 21 at 10:08 AM |
| Is the Options Market Predicting a Spike in Arbutus Biopharma (ABUS) Stock?
finance.yahoo.com - August 23 at 3:49 PM |
| Arbutus Biopharma (ABUS) Q2 2021 Earnings Call Transcript
finance.yahoo.com - August 7 at 11:15 AM |
| Arbutus Biopharma (ABUS) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - August 5 at 3:08 PM |
| Arbutus Reports Second Quarter 2021 Financial Results and Provides Corporate Update
finance.yahoo.com - August 5 at 10:08 AM |
| Arbutus Biopharma Corporation Common Stock (ABUS)
nasdaq.com - July 30 at 11:06 PM |
| Arbutus to Report Second Quarter 2021 Financial Results and Provide Corporate Update
finance.yahoo.com - July 29 at 12:57 PM |
 | Arbutus Biopharma Cp (ABUS-Q) Quote - Press Release - The Globe and Mail
theglobeandmail.com - July 15 at 6:34 PM |
|
| Arbutus Receives Authorization to Proceed with an Investigational New Drug Application (IND) for AB-729, its Proprietary Subcutaneously-Delivered RNAi Agent
finance.yahoo.com - July 7 at 8:46 AM |
| Bullish Arbutus Biopharma Analyst Breaks Down Pipeline Opportunity
markets.businessinsider.com - July 6 at 7:21 PM |
| Arbutus Biopharma and Antios Therapeutics Announce Clinical Collaboration Agreement to Evaluate AB-729 in Combination with ATI-2173 in Subjects with Chronic Hepatitis B Virus Infection
finance.yahoo.com - June 29 at 9:32 AM |
 | Arbutus Climbs on New Data
baystreet.ca - June 28 at 1:34 PM |
| Arbutus Higher After Report of Progress With Hepatitis B Drug
finance.yahoo.com - June 28 at 1:34 PM |
| Premarket Movers Monday: Intellia Therapeutics, Boeing, Nvidia
finance.yahoo.com - June 28 at 1:34 PM |
| Arbutus Biopharma Stock Jumps On Encouraging Data From Hepatitis B Candidate
finance.yahoo.com - June 28 at 1:34 PM |
| Here's Why We're Not Too Worried About Arbutus Biopharma's (NASDAQ:ABUS) Cash Burn Situation
finance.yahoo.com - June 15 at 11:05 AM |
| Arbutus Announces Multiple Abstracts Accepted for Oral and Poster Presentations at the EASL 2021 International Liver Congress in June
finance.yahoo.com - June 2 at 12:19 PM |
| Arbutus to Participate in Upcoming Investor Conferences
finance.yahoo.com - May 26 at 8:12 AM |
 | Arbutus Biopharma Corporation (ABUS) CEO Bill Collier on Q1 2021 Results - Earnings Call Transcript
seekingalpha.com - May 7 at 3:05 PM |
| Why Arbutus Biopharma's Stock Is Trading Lower Today
msn.com - May 5 at 5:06 PM |
| Arbutus Reports First Quarter 2021 Financial Results and Provides Corporate Update
markets.businessinsider.com - May 5 at 12:06 PM |
| Arbutus to Report First Quarter 2021 Financial Results and Provide Corporate Update
finance.yahoo.com - April 28 at 10:27 AM |
| Introducing Arbutus Biopharma (NASDAQ:ABUS), The Stock That Zoomed 167% In The Last Year
finance.yahoo.com - April 16 at 9:01 AM |
| ABUS Apr 2021 7.500 call
au.finance.yahoo.com - March 22 at 9:15 PM |
| Arbutus Gets Go Ahead To Kick Off Phase 1a/1b Clinical Trial Of AB-836
finance.yahoo.com - March 17 at 12:46 PM |
